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Retinal vein occlusion is the second most common retinal
vasculopathy after diabetic retinopathy, and may result in
permanent vision loss [1]. Despite the fact that it has been
widely studied, the exact pathogenesis of central retinal
vein occlusion (CRVO) and branch retinal vein occlusion
(BRVO) remains poorly understood.
Systemic factors leading to retinal vein occlusion include
hypertension, cardiovascular disease, arteriosclerosis,
diabetes, hypertriglyceridemia, and hypercholesterolemia
[2–5]. Major local factors are increased intraocular pressure
and chronic open angle glaucoma [6]. An association
between hyperopia and retinal vein occlusion has been
made in several studies [7]. The main components that
comprise the refractive power of the eye include the dioptric
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This study examined whether axial length is a local risk factor for central retinal vein occlusion (CRVO)
and branch retinal vein occlusion (BRVO). The study group consisted of 40 patients with unilateral CRVO
and 77 patients with unilateral BRVO. The control group included 67 individuals who matched the study
group patients in age, systemic hypertension, and diabetes mellitus status. The axial lengths of affected
and fellow eyes of patients and controls were measured using A-scan ultrasonography. The axial length
of affected eyes was statistically significantly shorter than that of unaffected eyes in the BRVO group
(p < 0.05) but not in the CRVO group (p = 0.05). There were also statistically significant differences in
axial length between control eyes and affected eyes in both the CRVO group (p < 0.05) and BRVO group
(p < 0.05). Thus, shorter axial length could be a risk factor for developing CRVO and BRVO. The axial
lengths of affected eyes in retinal vein occlusion patients tend to be shorter than those of unaffected eyes,
especially in BRVO patients.
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power of the cornea and lens, the anterior chamber depth,
and the axial length. Hyperopia is not the primary result of
shorter axial length; the correlation between the variables is
small, except in extreme refractive errors [8]. However,
there is no general agreement on axial length as a
predisposing factor in retinal vein occlusion [9–13].
Therefore, we conducted this study to clarify the role of
axial length in retinal vein occlusion. If this anatomic
difference exists, it could be a predisposing factor for the
development of retinal vein occlusion.
MATERIALS AND METHODS
We studied the axial lengths of 40 patients with CRVO and
77 patients with BRVO between December 1998 and June
2002. The CRVO group included 15 women (37.5%) and 25
men (62.5%) with a mean age of 64.98 years. In the BRVO
group, there were 40 women (51.9%) and 37 men (48.1%)
with a mean age of 61.84 years. Patient selection criteria
included unilateral CRVO or BRVO with clear ocular media
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but without macroscopic macular edema, and a normal
opposite eye. Patients with persistent macular edema, a
history of any other retinal disease, eye trauma, intraocular
inflammation or ophthalmic surgery were excluded.
Ophthalmic examination included slit-lamp biomicroscopy,
measurement of intraocular pressure, indirect oph-
thalmoscopy, fundus photography, and fundus fluores-
cein angiography.
The control group included 67 adults registered for
cataract extraction but who had no other problems. There
were 33 women (49.3%) and 34 men (50.7%) with a mean age
of 61.39 years. All patients in the study and control groups
gave their informed consent to have axial length
measurements taken. Axial length was measured using
A-scan ultrasonography (Nidek Echoscan US-3300, Nidek
Co., Ltd., Gamagori, Japan) with a sound velocity of
1,550 m/sec. Five consecutive measurements were taken using
the manual direct contact technique. Patients were instructed
to fixate on a small red light within the center of the probe tip.
High quality, consistent measurements were then taken as
optimum axial length values. All measurements were taken by
the same person to minimize the risk of errors.
In patients with retinal vein occlusion, the axial lengths of
affected eyes were compared with those of healthy unaffected
eyes, and also with the axial lengths of control eyes at random.
Statistical analyses were performed using paired t tests,
one-way ANOVA, and Scheffe’s test. Statistical significance
was set at p less than 0.05.
RESULTS
Patient characteristics are shown in Table 1. There were no
significant differences between the groups in terms of age,
sex and disease factors, including diabetes and hypertension.
In the CRVO group, the right eye was affected in 20 patients
and the left eye in 20 patients. In the BRVO group, the right
eye was affected in 35 patients and the left eye in 42 patients.
In the control group, the mean axial lengths were 23.94 ±
0.94 mm in the right eye and 23.97 ± 0.79 mm in the left eye
(p = 0.55). In the CRVO group, the mean axial lengths were
23.33 ± 0.95 mm in the right eye and 23.37 ± 1.21 mm in the
left eye (p = 0.72). In the BRVO group, the mean axial lengths
were 23.26 ± 1.02 mm in the right eye and 23.19 ± 0.86 mm
in the left eye (p = 0.69). The mean axial lengths of affected
and unaffected eyes were 23.22 mm and 23.48 mm,
respectively, in the CRVO group (p = 0.05; Table 2) and
23.13 mm and 23.32 mm, respectively, in the BRVO group.
The mean axial length of affected eyes was shorter than that
of unaffected eyes in the BRVO group (p < 0.05; Table 2).
The axial lengths of affected eyes in the BRVO and
CRVO groups were different from those of random eyes in
the control group (p < 0.05 in CRVO vs random control eyes;
p < 0.05 in BRVO vs random control eyes; Table 3).
The axial lengths of affected eyes in patients with retinal
vein occlusion tended to be shorter than those of unaffected
eyes, especially in BRVO patients. Therefore, shorter axial
length could be a local risk factor in the pathogenesis of
BRVO and CRVO.
DISCUSSION
The results of previous studies that evaluated the role of
axial length in CRVO and BRVO patients are controversial.
For example, Ariturk and associates found that axial lengths
of affected eyes, but not fellow eyes, in BRVO patients were
significantly shorter than those in controls [14], and this
Table 1. Patient characteristics
Variables Control CRVO BRVO p†
n (%) n (%) n (%)
N 67 40 77
Sex 0.38
   Female 33 (49.3) 15 (37.5) 40 (51.9)
   Male 34 (50.7) 25 (62.5) 37 (48.1)
Age* (yr) 61.39 ± 7.32 64.98 ± 12.16 61.84 ± 10.47 0.16
Range 43.0–75.0 42.0– 89.0 41.0–87.0
Hypertension 38 (56.7) 27 (67.5) 47 (61.0) 0.54
Diabetes mellitus 13 (19.4) 7 (17.5) 15 (19.5) 0.96
*Mean ± standard deviation ; †Chi-squared test for categorical variables and one-way ANOVA for continuous variables. CRVO = central retinal
vein occlusion; BRVO = branch retinal vein occlusion.
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was confirmed by the work of Timmerman and colleagues
[10]. However, Simons et al found that axial length was not
a risk factor for BRVO [15]. We found a significant difference
in axial length between BRVO patients and control subjects.
We also noted a statistical difference between unaffected
and affected eyes in BRVO patients (p = 0.02).
Brown et al [16] and Kumar et al [17] found that the axial
length of affected eyes in CRVO patients was significantly
shorter than that in normal subjects. However, no difference
was observed between affected and unaffected eyes in
CRVO patients. In contrast, Ariturk et al reported that the
axial length of affected eyes was significantly shorter than
that of unaffected eyes in CRVO patients, and that the axial
length in CRVO patients was also significantly shorter than
that in normal subjects [14]. We did not find a statistically
significant difference in axial length between affected and
unaffected eyes in CRVO patients (p = 0.05), but we did find
a significant difference in axial length between affected
eyes in CRVO patients and normal controls.
This inconsistency may be partly attributed to the
different demographic characteristics of patients with BRVO
and CRVO and normal subjects, and partly to the use of
different statistical methods for comparison among studies
[12]. In addition, statistical methods vary depending on the
sample size and study design. However, there is general
agreement among all these studies, including the present
one, that axial lengths of eyes with either CRVO or BRVO
are generally shorter than those of eyes in control subjects.
The control group in most reported studies of axial length
in retinal vein occlusion consists of cataract patients without
retinal vein occlusion [14–19]. We also chose cataract patients
as our control group because there is no known or suspected
association between axial length and cataracts [10].
Therefore, the choice of our control group should not
confound our examination of the relationship between axial
length and retinal vein occlusion in any way.
Although retinal vein occlusions have been investigated
in various studies, their etiology remains unclear. In one
study, histopathologic analysis revealed thrombus formation
at or near the lamina cribrosa in CRVO patients [18] and
almost invariably at the arteriovenous junction in BRVO
patients [19]. The exact role of a shorter axial length in the
development of retinal vein occlusion is also unknown. It is
possible that in eyes with shorter axial lengths, the retinal
vein and artery are more tightly confined as they pass
through the lamina cribrosa, which may impair blood flow
in the vein [20,21]. The flow could be reduced further at the
level of the arteriovenous crossing. When blood flow
decreases, viscosity increases as a result of erythrocyte
aggregation. Reduced blood flow at these two levels, in
conjunction with increased blood viscosity and turbulence
in the narrowed lumen of the vein, could cause thrombosis.
The origin of retinal vein occlusion undoubtedly includes
systemic factors, such as hypertension and diabetes mellitus.
In our study, the prevalence of hypertension was 67.5% in
the CRVO group and 61.0% in the BRVO group; the
prevalence of diabetes mellitus was 17.5% in the CRVO
group and 19.5% in the BRVO group. These results
Table 2. Differences in axial length between affected and unaffected eyes in central retinal vein occlusion (CRVO) and branch
retinal vein occlusion (BRVO)
Length CRVO (n = 40) BRVO (n = 77)
Affected Unaffected Difference* Affected Unaffected Difference*
Mean ±  SD (mm) 23.22 ± 1.14 23.48 ± 1.01 –0.26 ± 0.82 23.13 ± 0.86 23.32 ± 1.02 –0.19 ± 0.71
Range 20.21–25.22 21.50–26.16 21.09–25.15 21.27– 27.83
p 0.05 0.02†
*Difference = affected eye axial length – unaffected eye axial length; †0.01 < p < 0.05.
Table 3. Axial lengths (mean ± standard deviation) of affected eyes in central retinal vein occlusion (CRVO) and branch retinal
vein occlusion (BRVO) and random eyes in the control group
Control CRVO BRVO
(n = 67) (n = 40) (n = 77) p*
Length (mm) 23.98 ±  0.84 23.22 ±  1.14† 23.13 ±  0.86† 0.0001
*One-way ANOVA; †p < 0.05 vs control.
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correspond well with reports in the literature [22].
Our data demonstrated a significant association between
shorter axial length and the potential risk of retinal vein
occlusion. We conclude that shorter axial length could be a
local risk factor for either CRVO or BRVO.
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